Breaking News Instant updates and real-time market news.

APRN

Blue Apron

$2.50

-0.01 (-0.40%)

, SBUX

Starbucks

$56.52

-0.62 (-1.09%)

12:59
05/15/18
05/15
12:59
05/15/18
12:59

Consultant believes Starbucks should buy Blue Apron, RetailWire says

Consultant Brittain Ladd makes the case that Blue Apron's (APRN) recently announced partnership with Costco (COST) is "a poor move" and he believes that an acquisition by Starbucks (SBUX) would be "Blue Apron's real meal ticket," according to RetailWire. Reference Link

APRN

Blue Apron

$2.50

-0.01 (-0.40%)

SBUX

Starbucks

$56.52

-0.62 (-1.09%)

COST

Costco

$196.16

0.31 (0.16%)

  • 15

    May

  • 18

    May

APRN Blue Apron
$2.50

-0.01 (-0.40%)

02/02/18
02/02/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. VF Corp. (VFC) initiated with an Overweight at Barclays. 2. JinkoSolar (JKS) initiated with a Sell at Vertical Group. 3. Chimerix (CMRX) initiated with a Buy at H.C. Wainwright. 4. Voyager Therapeutics (VYGR) initiated with an Overweight at Morgan Stanley. 5. Blue Apron (APRN) initiated with a Buy at Gabelli. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
02/14/18
ADAM
02/14/18
NO CHANGE
Target $8
ADAM
Buy
Blue Apron showing signs of stabilization, says Canaccord
Canaccord analyst Michael Graham said Blue Apron's Q4 results were generally inline with expectations, with EBITDA better than expected. The analyst said Blue Apron has had its share of challenges since its IPO, but he is cautiously optimistic given its low valuation, the resumption of marketing spending, reduced capex requirements, and the potential for partnerships and product expansion. Graham maintained his Buy rating and lowered his price target to $8 from $10 on Blue Apron shares.
02/16/18
NRCS
02/16/18
UPGRADE
NRCS
Neutral
Blue Apron upgraded to Neutral from Sell at Northcoast
02/16/18
02/16/18
UPGRADE

Neutral
Blue Apron upgraded to Neutral on retail partnership potential at Northcoast
As previously reported, Northcoast analyst Charles Cerankosky upgraded Blue Apron to Neutral from Sell. He noted that management is suggesting the company could be at breakeven EBITDA by year end, though he "is far less optimistic." Still, given the pressure of its negative cash flow, he thinks Blue Apron will explore a retail distribution partnership, which could have a potential headline benefit. However, Cerankosky added that he expects that even if such a retail distribution partnership was struck, he believes "disappointing sales at retail would likely force such a relationship to die quickly."
SBUX Starbucks
$56.52

-0.62 (-1.09%)

04/27/18
PIPR
04/27/18
NO CHANGE
Target $70
PIPR
Overweight
Piper reiterates Overweight rating on Starbucks with $70 price target
Starbucks' fiscal Q2 results, while a "lackluster performance on the surface," is more reflective of what is being done versus the prior-year period, Piper Jaffray analyst Nicole Miller Regan tells investors in a research note. The up 2% Americas comp was a highlight, while store-level margins down 220 basis points to 20% of sales is concerning to most investors, the analyst adds. She believes the May 16-17 analyst day should serve as a positive catalyst, but cautions that domestic comps "likely overshadow this from a near-term stock perspective." Regan's bull case model suggests 14% earnings growth is sustainable. She reiterates an Overweight rating on Starbucks with a $70 price target.
05/08/18
MSCO
05/08/18
NO CHANGE
Target $72
MSCO
Overweight
Starbucks packaged deal with Nestle a long-term positive, says Morgan Stanley
Morgan Stanley analyst John Glass called Starbucks' (SBUX) packaged coffee deal with Nestle (NSRGY) a long-term positive, noting that it opens up previously untapped markets and improves the business' growth profile. The deal should be dilutive in FY19 and accretive by FY21, added Glass, who has an Overweight rating and $72 price target on Starbucks shares.
04/27/18
OPCO
04/27/18
NO CHANGE
Target $66
OPCO
Outperform
Oppenheimer reiterates Outperform rating on Starbucks with $66 price target
Oppenheimer analyst Brian Bittner reiterated an Outperform rating and $66 price target on Starbucks following the company's in-line Q2 results. In a research note to investors, Bittner said the drivers discussed to elevate comparable sales are more likely to impact 2019 performance than 2018. Despite this, he sees limited downside risk to 2018 EPS estimates if comps stay at about 2% in the second half of the year and sees an improving risk/reward into fiscal 2019.
04/13/18
04/13/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Starbucks (SBUX) downgraded to Market Perform from Outperform at Cowen with analyst Andrew Charles saying his optimism about a comparable sales rebound in the Americas region is diminished as he sees intensified craft coffee competition along with expressing uncertainty on the timeline and magnitude of success with its loyalty efforts. 2. Diamond Offshore (DO) downgraded to Underperform from Neutral at Credit Suisse. 3. Zillow (Z, ZG) downgraded to Hold from Buy at Craig-Hallum with analyst Brad Berning citing the company's announcement that it is expanding its Instant Offers program to Phoenix in addition to Las Vegas and Orlando. 4. Nu Skin (NUS) downgraded to Hold from Buy at Deutsche Bank with analyst Steve Powers saying with the valuation at multi-year highs, the market is pricing in a "material acceleration" in sales and earnings trends. 5. Tenneco (TEN) downgraded to Neutral from Buy at Goldman Sachs with analyst David Tamberrino saying he sees the strategic rationale in the Federal-Mogul acquisition, but highlights near-term challenges from input costs. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
COST Costco
$196.16

0.31 (0.16%)

04/16/18
WELS
04/16/18
UPGRADE
Target $220
WELS
Outperform
Costco upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Edward Kelly upgraded Costco Wholesale to Outperform and raised his price target for the shares to $220 from $195. The analyst expects Costco to "sustain strong comp momentum" despite difficult comparisons, deliver improved membership trends, navigate rising retail cost pressures, and beat consensus expectations. The stock "looks to be on the cusp of its next leg up," Kelly tells investors in a research note. The analyst notes that while the current valuation is "high," it remains "well below peak levels."
04/16/18
04/16/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Costco (COST) upgraded to Outperform from Market Perform at Wells Fargo with analyst Edward Kelly saying he expects Costco to "sustain strong comp momentum" despite difficult comparisons, deliver improved membership trends, navigate rising retail cost pressures, and beat consensus expectations. 2. Boston Beer (SAM) upgraded to Neutral from Sell at Goldman Sachs. 3. Ulta Beauty (ULTA) upgraded to Buy from Neutral at Guggenheim with analyst Steven Forbes saying he believes Ulta's industry-leading position and secular growth potential is undervalued with shares trading at 10x 2019 EBITDA. 4. Nielsen (NLSN) upgraded to Outperform from Market Perform at BMO Capital with analyst Daniel Salmon saying the heightened regulation on open internet platforms is a positive for a company involved with measurement and verification of data, which could increase demand for its products. 5. C.H. Robinson (CHRW) upgraded to Buy from Neutral at UBS with analyst Thomas Wadewitz saying trends in the first quarter are very favorable, which points to strong Q1 results for the company. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/03/18
UBSW
05/03/18
NO CHANGE
Target $215
UBSW
Buy
Costco shares remain compelling, says UBS
UBS analyst Michael Lasser met with Costco (COST) management, who noted their prices are well below Amazon's (AMZN) and at an even steeper discount to Whole Foods. He said Costco's model continues to stand on its own and he believes the shares are compelling at current levels. Lasser reiterated his Buy rating and $215 price target on Costco shares.
04/12/18
BARD
04/12/18
NO CHANGE
Target $215
BARD
Outperform
Costco March traffic remained robust, sales impressive, says Baird
Baird analyst Peter Benedict said the traffic for Costco remained robust and the company posted impressive same store sales in March. He said the results underscore the durability and relevancy of its business model and he remains a buyer of the shares. Benedict reiterated his Outperform rating and $215 price target on Costco shares.

TODAY'S FREE FLY STORIES

M

Macy's

$35.77

-1.27 (-3.43%)

08:08
11/14/18
11/14
08:08
11/14/18
08:08
Hot Stocks
Macy's on track to deliver 'strong' holiday season, Q4 »

Macy's notes higher…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

MYO

Myomo

$1.99

0.02 (1.02%)

08:07
11/14/18
11/14
08:07
11/14/18
08:07
Hot Stocks
Myomo announces first adolescent patients to be fitted with MyoPro »

Myomo has achieved recent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPWR

SunPower

$6.13

-0.22 (-3.46%)

, CBT

Cabot

$48.27

-0.15 (-0.31%)

08:07
11/14/18
11/14
08:07
11/14/18
08:07
Hot Stocks
SunPower, Cabot announce helix solar-plus-storage agreement »

Cabot (CBT) announced…

SPWR

SunPower

$6.13

-0.22 (-3.46%)

CBT

Cabot

$48.27

-0.15 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

DRIO

DarioHealth

$0.90

-0.18 (-16.67%)

, BBY

Best Buy

$67.06

-0.08 (-0.12%)

08:06
11/14/18
11/14
08:06
11/14/18
08:06
Hot Stocks
DarioHealth's diabetes digital solution available at Best Buy »

DarioHealth's (DRIO)…

DRIO

DarioHealth

$0.90

-0.18 (-16.67%)

BBY

Best Buy

$67.06

-0.08 (-0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLNT

Planet Fitness

$52.09

1 (1.96%)

, C

Citi

$64.78

0.55 (0.86%)

08:05
11/14/18
11/14
08:05
11/14/18
08:05
Hot Stocks
Planet Fitness enters into $300M accelerated share repurchase program »

Planet Fitness (PLNT) has…

PLNT

Planet Fitness

$52.09

1 (1.96%)

C

Citi

$64.78

0.55 (0.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 14

    Jan

  • 15

    Apr

  • 13

    Jul

M

Macy's

$35.77

-1.27 (-3.43%)

08:05
11/14/18
11/14
08:05
11/14/18
08:05
Earnings
Macy's raises FY18 EPS view to $4.10-$4.30 from $3.95-$4.15, consensus $4.07 »

Narrows FY18 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

CI

Cigna

$213.00

-4.51 (-2.07%)

08:05
11/14/18
11/14
08:05
11/14/18
08:05
Hot Stocks
Cigna, Annum Health collaborate on digital health support solution »

Cigna is collaborating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTAP

NetApp

$78.90

0.04 (0.05%)

, PSTG

Pure Storage

$19.41

0.13 (0.67%)

08:04
11/14/18
11/14
08:04
11/14/18
08:04
Recommendations
NetApp, Pure Storage analyst commentary  »

Checks point to continued…

NTAP

NetApp

$78.90

0.04 (0.05%)

PSTG

Pure Storage

$19.41

0.13 (0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 19

    Nov

  • 26

    Nov

FL

Foot Locker

$51.05

0.185 (0.36%)

, NKE

Nike

$75.22

0.14 (0.19%)

08:03
11/14/18
11/14
08:03
11/14/18
08:03
Recommendations
Foot Locker, Nike analyst commentary  »

Foot Locker well…

FL

Foot Locker

$51.05

0.185 (0.36%)

NKE

Nike

$75.22

0.14 (0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

NLSN

Nielsen

$26.54

0.11 (0.42%)

, CMCSA

Comcast

$37.72

-0.3 (-0.79%)

08:02
11/14/18
11/14
08:02
11/14/18
08:02
Hot Stocks
Nielsen to measure digital audiences of Comcast's Xfinity TV »

Nielsen (NLSN) and…

NLSN

Nielsen

$26.54

0.11 (0.42%)

CMCSA

Comcast

$37.72

-0.3 (-0.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGEN

Seattle Genetics

$54.84

-0.18 (-0.33%)

08:02
11/14/18
11/14
08:02
11/14/18
08:02
Hot Stocks
Seattle Genetics initiates Phase 1 clinical trial of SEA-BCMA »

Seattle Genetics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

  • 03

    Dec

SABR

Sabre

$25.17

0.27 (1.08%)

08:02
11/14/18
11/14
08:02
11/14/18
08:02
Hot Stocks
Sabre to acquire Farelogix for approximately $360M »

Sabre announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

M

Macy's

$35.77

-1.27 (-3.43%)

08:01
11/14/18
11/14
08:01
11/14/18
08:01
Earnings
Macy's reports Q3 adj. EPS 27c, consensus 14c »

Reports Q3 revenue $5.4B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

NFLX

Netflix

$294.65

0.63 (0.21%)

08:01
11/14/18
11/14
08:01
11/14/18
08:01
Periodicals
Netflix testing lower price mobile-only offering in Malaysia, TechCrunch reports »

Netflix is testing a …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 04

    Dec

08:00
11/14/18
11/14
08:00
11/14/18
08:00
General news
Fedspeak from Fed Chairman Powell »

Fedspeak from Fed…

PANW

Palo Alto Networks

$176.94

-0.36 (-0.20%)

07:59
11/14/18
11/14
07:59
11/14/18
07:59
Recommendations
Palo Alto Networks analyst commentary  »

Palo Alto Networks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

  • 19

    Nov

  • 29

    Nov

  • 10

    Dec

  • 09

    Jan

CBRE

CBRE Group

07:59
11/14/18
11/14
07:59
11/14/18
07:59
Recommendations
CBRE Group analyst commentary  »

CBRE fundamentals intact,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARMK

Aramark

$35.44

0.845 (2.44%)

07:59
11/14/18
11/14
07:59
11/14/18
07:59
Upgrade
Aramark rating change  »

Aramark upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BWXT

BWX Technologies

$42.34

-1.849 (-4.18%)

07:58
11/14/18
11/14
07:58
11/14/18
07:58
Initiation
BWX Technologies initiated  »

BWX Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FMC

FMC Corporation

$81.25

-0.97 (-1.18%)

07:58
11/14/18
11/14
07:58
11/14/18
07:58
Initiation
FMC Corporation initiated  »

FMC Corporation initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

LTHM

Livent

$17.80

-0.55 (-3.00%)

07:57
11/14/18
11/14
07:57
11/14/18
07:57
Initiation
Livent initiated  »

Livent initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBAY

eBay

$28.10

-0.86 (-2.97%)

07:56
11/14/18
11/14
07:56
11/14/18
07:56
Recommendations
eBay analyst commentary  »

eBay tracker shows…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

GPI

Group 1 Automotive

$56.20

-1.13 (-1.97%)

07:55
11/14/18
11/14
07:55
11/14/18
07:55
Upgrade
Group 1 Automotive rating change  »

Group 1 Automotive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIX

Wix.com

$91.30

2.83 (3.20%)

07:55
11/14/18
11/14
07:55
11/14/18
07:55
Recommendations
Wix.com analyst commentary  »

Wix.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

IQ

iQIYI

$20.33

0.77 (3.94%)

, CBS

CBS

$57.02

-0.125 (-0.22%)

07:55
11/14/18
11/14
07:55
11/14/18
07:55
Hot Stocks
iQIYI licenses CBS Studios' "The Late Late Show with James Corden" in China »

iQIYI (IQ) and CBS (CBS)…

IQ

iQIYI

$20.33

0.77 (3.94%)

CBS

CBS

$57.02

-0.125 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.